| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113622 | Critical Reviews in Oncology/Hematology | 2015 | 12 Pages |
Abstract
Acknowledging for heterogeneity in data sources, prevention of unexpected DDIs during clinical trials may be improved by using this list of preferred drugs for the management of study patient's symptoms.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Florence Ranchon, Thierry Vial, Catherine Rioufol, Emilie Hénin, Claire Falandry, Gilles Freyer, Véronique Trillet-Lenoir, Christophe Le Tourneau, Benoit You,